Sulfamethoxypyridazine

CAS No. 80-35-3

Sulfamethoxypyridazine( Sulfamethoxypyridazine | Lisulfen | Longin | Medicel | Midicel | Midikel | Myasul )

Catalog No. M16007 CAS No. 80-35-3

Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 39 In Stock
500MG 68 In Stock
1G 99 In Stock

Biological Information

  • Product Name
    Sulfamethoxypyridazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
  • Description
    Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Sulfamethoxypyridazine | Lisulfen | Longin | Medicel | Midicel | Midikel | Myasul
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    80-35-3
  • Formula Weight
    280.3
  • Molecular Formula
    C11H12N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 56 mg/mL (199.78 mM)
  • SMILES
    O=S(C1=CC=C(N)C=C1)(NC2=NN=C(OC)C=C2)=O
  • Chemical Name
    Benzenesulfonamide, 4-amino-N-(6-methoxy-3-pyridazinyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tafintseva Iiu, et al. Prikl Biokhim Mikrobiol. 2010 Mar-Apr; 46(2):232-6.
molnova catalog
related products
  • MMP-8 Substrate, flu...

    MMP-8/MMP-26 Fluorogenic substrate (DNP-Pro-Leu-Ala-Tyr-Trp-Ala-Arg) is a matrix metalloproteinase-8 (MMP-8) fluorogenic substrate. MMP-8/MMP-26 Fluorogenic substrate can be used for the research of atherosclerosis, pulmonary fibrosis, and sepsis.

  • BT44

    BT44 is a novel, second-generation glial cell linederived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders.

  • 1-Hydroxybaccatin I

    1-Hydroxybaccatin I possesses significant antinociceptive activity against p- benzoquinone-induced abdominal contractions.